Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
New prophylactic and therapeutic strategies to combat human infections with highly pathogenic avian influenza (HPAI) H5N1 viruses are needed. We generated neutralizing anti-H5N1 human monoclonal antibodies (mAbs) and tested their efficacy for prophylaxis and therapy in a murine model of infection.Us...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-05-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC1880850?pdf=render |